FABP4 is considered a biomarker for cardiac fibrosis, while the FABP4 level improved in cardiac fibrosis patients may speculate the association of FABP4 in myocardial fibrosis and the advancement of cardiac fibrosis. Here, FABP4 is linked to Myocardial fibrosis.